Stabilize Patients During Treatment Ramp-Up — Measurably.

Validated for GLP-1 programs.

8-week stabilization pilot for owner-led clinics.

No EMR integration. No workflow disruption.

No Protected Health Information (PHI) collected or stored during pilot.

Because the pilot does not collect Protected Health Information (PHI), a Business Associate Agreement (BAA) is not required during pilot participation.

Structured retention validation for GLP-1 programs.

Limited to 6 owner-led clinics.

The Market Context

GLP-1 therapies now serve 15M+ patients in the United States, across 75,000–125,000 medical weight-loss and longevity clinics.

Early-phase patient instability is emerging as one of the most common operational challenges during treatment ramp-up.

The First 60 Days Determine Everything.

Most GLP-1 programs experience the highest patient drop-off within the first 8 weeks.

Revenue volatility

Unpredictable monthly recurring revenue (MRR)

Increased support load

Food-related questions during dose escalation

Reactive staff workflows

Constant firefighting instead of structured support

Unpredictable refill timing

Inventory and cash flow planning challenges

Stopping early churn has a disproportionately large impact on patient lifetime value.

Preview the System

Explore the clinic dashboard and patient portal before applying.

Preview the Interface Before Applying

Explore the clinic dashboard and patient experience:

Apply for the Pilot Cohort

Pilot Cohort

Limited to 6 Clinics for Initial Validation

Check your clinic's eligibility for the 8-week stabilization pilot.

Takes about 20 seconds • Applications reviewed within 48 hours